Acetocaustin
Acetocaustin is a medicine authorised by Swissmedic under authorisation number 45209. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 November 1984 and the authorisation is valid without a time limit. ATC code D11AF places the medicine in the group Other dermatological preparations.
| Authorisation number | 45209 |
|---|---|
| Name | Acetocaustin |
| Full name | Acetocaustin, Lösung |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D11AF |
| First authorisation | 30 November 1984 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Acetocaustin, Lösung | B | 30 November 1984 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 32 | 1 ml | Flasche(n) | D11AF | 10.07.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Acetocaustin authorised in Switzerland?
Yes. Acetocaustin is authorised by Swissmedic under authorisation number 45209, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Acetocaustin have?
Acetocaustin is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Acetocaustin?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.